Investment House LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
12,997
-1,000
-7% -$57.4K 0.04% 156
2026
Q1
$849K Buy
13,997
+125
+0.9% +$7.29K 0.04% 149
2025
Q4
$748K Buy
13,872
+150
+1% +$7.22K 0.04% 154
2025
Q3
$619K Sell
13,722
-18,277
-57% -$854K 0.03% 166
2025
Q2
$1.48M Sell
31,999
-19,186
-37% -$942K 0.07% 127
2025
Q1
$3.12M Sell
51,185
-724
-1% -$42.2K 0.18% 94
2024
Q4
$2.94M Buy
51,909
+1,849
+4% +$103K 0.16% 95
2024
Q3
$2.59M Buy
50,060
+4,665
+10% +$219K 0.14% 104
2024
Q2
$1.89M Buy
45,395
+12,825
+39% +$574K 0.11% 107
2024
Q1
$1.77M Buy
32,570
+12,575
+63% +$641K 0.1% 106
2023
Q4
$1.03M Sell
19,995
-4,868
-20% -$256K 0.07% 120
2023
Q3
$1.44M Sell
24,863
-10,027
-29% -$614K 0.11% 103
2023
Q2
$2.23M Sell
34,890
-25,000
-42% -$1.68M 0.17% 89
2023
Q1
$4.15M Sell
59,890
-585
-1% -$41.3K 0.34% 70
2022
Q4
$4.35M Sell
60,475
-4,290
-7% -$323K 0.41% 64
2022
Q3
$4.6M Buy
64,765
+2,563
+4% +$186K 0.43% 60
2022
Q2
$4.79M Buy
62,202
+15,275
+33% +$1.16M 0.42% 61
2022
Q1
$3.43M Sell
46,927
-8,839
-16% -$593K 0.25% 72
2021
Q4
$3.48M Sell
55,766
-9,680
-15% -$568K 0.22% 75
2021
Q3
$3.87M Buy
65,446
+713
+1% +$47K 0.28% 67
2021
Q2
$4.33M Buy
64,733
+5,195
+9% +$339K 0.3% 66
2021
Q1
$3.76M Buy
59,538
+3,631
+6% +$226K 0.29% 69
2020
Q4
$3.47M Buy
55,907
+8,540
+18% +$525K 0.24% 76
2020
Q3
$2.86M Buy
47,367
+1,760
+4% +$106K 0.22% 75
2020
Q2
$2.68M Buy
45,607
+2,472
+6% +$148K 0.24% 78
2020
Q1
$2.4M Buy
43,135
+5,727
+15% +$350K 0.27% 75
2019
Q4
$2.4M Buy
37,408
+16,614
+80% +$951K 0.22% 83
2019
Q3
$1.05M Sell
20,794
-2,050
-9% -$96.3K 0.11% 108
2019
Q2
$1.04M Sell
22,844
-7,360
-24% -$343K 0.11% 102
2019
Q1
$1.44M Sell
30,204
-6,025
-17% -$300K 0.16% 99
2018
Q4
$1.88M Sell
36,229
-3,275
-8% -$176K 0.23% 84
2018
Q3
$2.45M Sell
39,504
-200
-0.5% -$11.9K 0.26% 83
2018
Q2
$2.2M Buy
39,704
+100
+0.3% +$5.4K 0.25% 85
2018
Q1
$2.5M Sell
39,604
-500
-1% -$32.2K 0.31% 80
2017
Q4
$2.46M Sell
40,104
-925
-2% -$57.9K 0.3% 81
2017
Q3
$2.62M Buy
41,029
+600
+1% +$35K 0.34% 77
2017
Q2
$2.25M Buy
40,429
+455
+1% +$24.8K 0.3% 80
2017
Q1
$2.17M Sell
39,974
-1,135
-3% -$62.3K 0.31% 83
2016
Q4
$2.4M Sell
41,109
-3,395
-8% -$186K 0.37% 79
2016
Q3
$2.4M Sell
44,504
-21,940
-33% -$1.41M 0.36% 80
2016
Q2
$4.89M Buy
66,444
+5,450
+9% +$385K 0.78% 48
2016
Q1
$3.9M Buy
60,994
+2,025
+3% +$128K 0.62% 57
2015
Q4
$4.06M Buy
58,969
+3,130
+6% +$207K 0.66% 52
2015
Q3
$3.31M Buy
55,839
+1,450
+3% +$92K 0.58% 62
2015
Q2
$3.62M Buy
54,389
+22,475
+70% +$1.48M 0.58% 65
2015
Q1
$2.06M Hold
31,914
0.33% 86
2014
Q4
$1.88M Sell
31,914
-436
-1% -$24.6K 0.3% 84
2014
Q3
$1.66M Hold
32,350
0.28% 89
2014
Q2
$1.57M Buy
32,350
+500
+2% +$24.6K 0.27% 89
2014
Q1
$1.65M Buy
31,850
+1,475
+5% +$78.5K 0.29% 86
2013
Q4
$1.61M Buy
30,375
+1,700
+6% +$86.6K 0.29% 81
2013
Q3
$1.33M Buy
28,675
+200
+0.7% +$8.78K 0.27% 81
2013
Q2
$1.27M Buy
+28,475
New +$1.24M 0.28% 81

Other funds holding BMY

Investment House LLC's BMY Position: Q2 2026 in Review

Investment House LLC reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q2 2026, selling an estimated $57.4K and leaving 12,997 shares worth $788K. The position accounts for 0.04% of the portfolio, ranked #156.

Investment House LLC first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.89M in Q2 2016. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Investment House LLC held 12,997 shares of Bristol-Myers Squibb worth $788K as of Q2 2026.
  • Investment House LLC sold 1,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $57.4K.
  • Bristol-Myers Squibb made up 0.04% of Investment House LLC's portfolio in Q2 2026, its #156 holding.
  • Investment House LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Investment House LLC's Bristol-Myers Squibb position peaked at $4.89M in Q2 2016.
  • 936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.